A股異動 | 九安醫療漲停 公司生產體温計為抗擊疫情做出貢
格隆匯2月3日丨九安醫療(002432.SZ)漲停,報6.23元,總市值27億元。小米科技和九安醫療組織首批救援物資發往武漢,並協調物流和進城手續,1月24日當天18點完成裝車,九安醫療(002432)首批捐贈物資1000支iHealth體温計和小米物資一起出發,去往武漢。28日上午,九安醫療所有在津工作人員200餘人放棄假期回到企業,走上生產一線,一起啟動電子測温設備生產,為抗擊疫情做出貢獻。目前生產電子測温設備以iHealth額温計為主,生產目標是每天5000支。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.